Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 2/20 | 0.43 |
| ▸ | ITPR3 | Q14573 | 3/20 | 0.35 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.35 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.35 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.32 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30240916 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL1065994 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL5523617 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL23563167 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL14268493 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL23563168 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL9300366 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL8581971 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL14437195 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 | |
| SCHEMBL8582671 | 0.85 | ITPR3 (0.45) | P2RY14ITPR3ITPR2ITPR1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0650492-A1 | REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS | ALBERTA RESEARCH COUNCIL (CA) | 1995-05-03 | — | — | EP | disclosed |
| EP-0591256-A1 | METHODS FOR THE SYNTHESIS OF MONOFUCOSYLATED OLIGOSACCHARIDES TERMINATING IN DI-N-ACETYLLACTOSAMINYL STRUCTURES | GLYCOMED INCORPORATED (US) | 1994-04-13 | — | — | EP | disclosed |
| WO-1992022662-A1 | METHODS FOR THE SYNTHESIS OF MONOFUCOSYLATED OLIGOSACCHARIDES TERMINATING IN DI-N-ACETYLLACTOSAMINYL STRUCTURES | ALBERTA RESEARCH COUNCIL (CA) | 1992-12-23 | — | — | WO | disclosed |